Pharmaceuticals, Biotechnology and Life Sciences
TAMPA, Fla.–(BUSINESS WIRE)–#AAIC2019–Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that its senior management team led by Stephan Jackman,…
BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Reissuing release dated June 24th, 2019 to correct for searching purposes. The corrected release reads: MAGENTA THERAPEUTICS APPOINTS…
DUBLIN–(BUSINESS WIRE)–The “Aminoglycosides Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Global Primary Biliary Cholangitis Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This will boost the…
–(BUSINESS WIRE)–Organigram Holdings Inc. is a NASDAQ Global Select and TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram…
DUBLIN–(BUSINESS WIRE)–The “Imbruvica” report has been added to ResearchAndMarkets.com’s offering. Imbruvica (ibrutinib; AbbVie/Johnson & Johnson) is an oral small molecule…
DUBLIN–(BUSINESS WIRE)–The “Global Japanese Encephalitis Vaccines Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. Global Japanese Encephalitis Vaccines Market:…
DUBLIN–(BUSINESS WIRE)–The “Rituxan” report has been added to ResearchAndMarkets.com’s offering. Rituxan (rituximab; Biogen/Roche/Chugai/Zenyaku Kogyo) is a murine/human chimeric cluster of…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has postponed its 2019 annual meeting of stockholders.…